M. Bear

Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma - a phase II study.

S. Stilgenbauer, L. Gelbert, S. Buchanan, 2020, Haematologica.

A phase II study of abemaciclib in patients (pts) with brain metastases (BM) secondary to HR+, HER2- metastatic breast cancer (MBC).

C. Anders, P. Kabos, A. Awada, 2019, Journal of Clinical Oncology.

nextMONARCH: Abemaciclib Monotherapy or Combined With Tamoxifen for Metastatic Breast Cancer.

J. Huober, G. Jerusalem, Miguel Martín, 2020, Clinical breast cancer.

A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–Positive Breast Cancer

N. Lin, C. Anders, P. Kabos, 2020, Clinical Cancer Research.